Open label study to confirm effectiveness, safety and pharmacokinetics of fentanyl transdermal matrix patch, in Japanese patients with cancer pain who have had a minimum amount of morphine therapy, such as equal to less than 45 mg/day of oral morphine or oxycodone equal to less than 30 mg/day
Phase of Trial: Phase II
Latest Information Update: 20 Jan 2011
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- 15 Nov 2005 New trial record.